|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4789734A
(en)
|
1985-08-06 |
1988-12-06 |
La Jolla Cancer Research Foundation |
Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
|
|
CH671155A5
(cg-RX-API-DMAC7.html)
|
1986-08-18 |
1989-08-15 |
Clinical Technologies Ass |
|
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
CA2153391C
(en)
|
1993-01-11 |
2000-08-15 |
Kenneth Rock |
Inducing cytotoxic t lymphocyte responses
|
|
WO1997039776A1
(en)
|
1996-04-19 |
1997-10-30 |
Genetic Therapy, Inc. |
Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
|
|
US6207392B1
(en)
|
1997-11-25 |
2001-03-27 |
The Regents Of The University Of California |
Semiconductor nanocrystal probes for biological applications and process for making and using such probes
|
|
US20010006948A1
(en)
*
|
1998-11-25 |
2001-07-05 |
James D. Kang |
Gene transfer to intervertebral disc cells
|
|
AU2001250912B2
(en)
|
2000-03-21 |
2007-01-04 |
Curagen Corporation |
VEGF-modulated genes and methods employing them
|
|
EP1381276A4
(en)
|
2001-04-13 |
2005-02-02 |
Univ Pennsylvania |
METHOD FOR TREATMENT OR DEVELOPMENT SLUDGE DEGRADATION
|
|
US20040072774A1
(en)
*
|
2002-02-23 |
2004-04-15 |
Giovanni Manfredi |
Methods for expressing and targeting mitochondrial-DNA-encoded peptides and uses thereof
|
|
US7405284B2
(en)
*
|
2002-10-18 |
2008-07-29 |
University Of Florida Research Foundation, Inc. |
Reducing cellular dysfunction caused by mitochondrial gene mutations
|
|
BRPI0511764B8
(pt)
*
|
2004-06-01 |
2021-05-25 |
Avigen Inc |
método de prevenção de agregação de vírions de vírus adeno-associado recombinante (raav) em uma preparação purificada de virions raav
|
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
|
EP2913403A1
(en)
*
|
2005-05-03 |
2015-09-02 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Importation of mitochondrial protein by an enhanced allotopic approach
|
|
WO2008063802A2
(en)
|
2006-10-23 |
2008-05-29 |
University Of Florida Research Foundation, Inc. |
Suppression of mitochondrial oxidative stress
|
|
US20100022517A1
(en)
*
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
|
JP2010538244A
(ja)
|
2007-06-20 |
2010-12-09 |
ガラパゴス・ナムローゼ・フェンノートシャップ |
骨及び関節の変性疾患の治療に有用な分子標的及び化合物並びにその同定方法
|
|
WO2010048352A2
(en)
|
2008-10-22 |
2010-04-29 |
Quark Pharmaceuticals, Inc. |
Methods for treating eye disorders
|
|
ES2680915T3
(es)
|
2010-01-28 |
2018-09-11 |
The Children's Hospital Of Philadelphia |
Plataforma de fabricación escalable para la purificación de vectores virales y vectores virales purificados de este modo para su utilización en terapia génica
|
|
CN102517304B
(zh)
|
2011-12-16 |
2013-08-28 |
中国农业科学院生物技术研究所 |
重组葡萄糖氧化酶的优化基因及其表达载体和应用
|
|
US20160289674A1
(en)
|
2012-04-02 |
2016-10-06 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
|
EP2834260A4
(en)
*
|
2012-04-02 |
2016-08-10 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PREPARATION OF MEMBRANE PROTEINS
|
|
CN102634527B
(zh)
|
2012-04-11 |
2013-11-06 |
华中科技大学同济医学院附属同济医院 |
重组人nadh脱氢酶亚单位4基因及其表达载体构建方法
|
|
TWI690322B
(zh)
|
2012-10-02 |
2020-04-11 |
法商傳斯堅公司 |
含病毒的調配物及其使用
|
|
US9066966B2
(en)
*
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
|
US9567376B2
(en)
*
|
2013-02-08 |
2017-02-14 |
The Trustees Of The University Of Pennsylvania |
Enhanced AAV-mediated gene transfer for retinal therapies
|
|
EP2992892A1
(en)
*
|
2014-09-05 |
2016-03-09 |
Universität zu Köln |
Fusion protein for use in the treatment of mitochondrial diseases
|
|
CA2961568A1
(en)
|
2014-09-17 |
2016-03-24 |
The University Of Iowa Research Foundation |
Viral rna segments as immunomodulatory agents and vaccine components
|
|
CN104450747B
(zh)
*
|
2014-09-23 |
2018-02-09 |
武汉纽福斯生物科技有限公司 |
用于治疗Leber遗传性视神经病变的重组腺相关病毒‑NADH脱氢酶亚单位4基因全长以及药剂
|
|
US11052094B2
(en)
*
|
2015-05-29 |
2021-07-06 |
Sydnexis, Inc. |
D2O stabilized pharmaceutical formulations
|
|
AU2016291778B2
(en)
|
2015-07-13 |
2021-05-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
CN110049769A
(zh)
|
2016-12-04 |
2019-07-23 |
阿拉维·霍拉萨尼·默哈达姆·马塞尔·维克托 |
治疗与线粒体应激相关的疾病的方法
|
|
US20180207293A1
(en)
|
2017-01-25 |
2018-07-26 |
2C Tech Corp. |
Nanoparticles for sustained ophthalmic drug delivery and methods of use
|
|
CN119752819A
(zh)
*
|
2017-03-01 |
2025-04-04 |
宾夕法尼亚州立大学托管会 |
用于眼部病症的基因疗法
|
|
EP4234025A3
(en)
|
2017-08-11 |
2024-04-24 |
Unity Biotechnology, Inc. |
Treatment of diabetic retinopathy using pharmaceutical agents that eliminate senescent cells
|
|
EP3781695A4
(en)
|
2018-04-16 |
2022-01-26 |
The Children's Hospital of Philadelphia |
IMPORT OF MITOCHONDRIAL RNA FOR TREATMENT OF MITOCHONDRIAL DISEASE
|
|
AU2019286386B2
(en)
|
2018-06-11 |
2025-05-29 |
Gensight Biologics Sa |
Recombinant AAV vectors and methods of using the same
|
|
CN111068071A
(zh)
|
2018-10-22 |
2020-04-28 |
武汉纽福斯生物科技有限公司 |
基因治疗Leber遗传学视神经病变
|
|
CN111073899B
(zh)
|
2018-10-19 |
2021-01-01 |
武汉纽福斯生物科技有限公司 |
一种编码人nadh脱氢酶亚单位4蛋白的核酸及其应用
|
|
EP3814492A4
(en)
|
2018-06-29 |
2022-02-23 |
Wuhan Neurophth Biotechnology Limited Company |
COMPOSITIONS AND METHODS OF TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
|
|
WO2020010491A1
(zh)
|
2018-07-09 |
2020-01-16 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位4蛋白的核酸及其应用
|
|
CN110846392A
(zh)
|
2018-08-20 |
2020-02-28 |
武汉纽福斯生物科技有限公司 |
一种重组腺相关病毒或含其的试剂盒及其应用
|
|
WO2020038352A1
(en)
|
2018-08-20 |
2020-02-27 |
Wuhan Neurophth Biological Technology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
|
SG11202101032VA
(en)
|
2018-08-20 |
2021-02-25 |
Wuhan Neurophth Biotechnology Ltd Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
|
CN113025633B
(zh)
|
2019-12-09 |
2024-08-27 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|